Clinical Trial Update: Safety and Efficacy of Empagliflozin in GSD1b Patients With Neutropenia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating empagliflozin for safety and efficacy in GSD1b patients with neutropenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose 6 Phosphatase Deficiency

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Children's Memorial Health Institute, Poland | Conditions: Glucose 6 Phosphatase Deficiency | Phase 2 | Status: UNKNOWN